Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  DaVita    DVA

DAVITA (DVA)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/16 10:02:01 pm
73.65 USD   -0.26%
02/14DAVITA : cuts 38 jobs in Minneapolis
AQ
02/14DAVITA : Around nm
AQ
02/14DAVITA : Kidney Care Encourages Americans to Become Organ Donors
PR
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Davita : Rep. Norman will hear from Fort Mill patients. What will they say?

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/13/2017 | 02:04am CET

Aug. 13--FORT MILL -- U.S. Rep. Ralph Norman, R-S.C., will speak with dialysis patients at 10 a.m. Monday at Fort Mill's DaVita Dialysis Center.

Norman, who was elected earlier this summer to the U.S. House of Representatives, is touring South Carolina's5th District on a listening tour before the Congressional recess ends in early September.

Norman will meet with patients and their families to hear about the "benefits of integrated care for kidney patients," according to DaVita. The congressman will hear stories about the care needed for patients living with end stage renal disease who require dialysis to survive.

DaVita says Congress will consider many important public policy issues impacting kidney care and patients in South Carolina. Norman campaigned for his Congress seat on a promise to repeal the Affordable Care Act, or "Obamacare."

A Senate bill that would strip away most of that law failed last month to gain enough Republican votes to pass.

Norman told The Herald he is looking forward to returning to Washington, D.C., to work with his colleagues on a new replacement bill.

"I haven't talked to a person yet who is happy with their insurance," he said. "They can't afford their premiums, and God help them if they get sick."

David Thackham: 803-329-4066, @dthackham

___

(c)2017 The Herald (Rock Hill, S.C.)

Visit The Herald (Rock Hill, S.C.) at www.heraldonline.com

Distributed by Tribune Content Agency, LLC.

© Tribune Content Agency, source Regional News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DAVITA
02/14DAVITA : cuts 38 jobs in Minneapolis
AQ
02/14DAVITA : Around nm
AQ
02/14DAVITA : Kidney Care Encourages Americans to Become Organ Donors
PR
02/07DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
02/05DAVITA : Government Report Reveals Dialysis Industry Improves Patient Care
PR
02/01DAVITA : Kidney Care Promotes Heart-Healthy Lifestyles During American Heart Mon..
PU
01/31DAVITA INC. : Schedules 4th Quarter 2017 Investor Conference Call
PR
01/31THE EVERETT CLINIC : Announces Senior Leadership Transitions
PR
01/23DAVITA : Recognized as a Top Green Company by Newsweek
PR
01/22DAVITA : Named Inaugural Member of Bloomberg Gender-Equality Index 2018
PR
More news
News from SeekingAlpha
02/18SA INTERVIEW : Special Situation Value Investing With Angry Uptick 
02/15Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2017 Update 
02/14DaVita HealthCare Partners' (DVA) CEO Kent Thiry on Q4 2017 Results - Earning.. 
02/13DaVita HealthCare Partners EPS of $0.92 
02/12Notable earnings after Tuesday?s close 
Financials ($)
Sales 2018 11 455 M
EBIT 2018 1 555 M
Net income 2018 657 M
Debt 2018 5 999 M
Yield 2018 -
P/E ratio 2018 18,32
P/E ratio 2019 13,74
EV / Sales 2018 1,71x
EV / Sales 2019 1,80x
Capitalization 13 535 M
Chart DAVITA
Duration : Period :
DaVita Technical Analysis Chart | DVA | US23918K1088 | 4-Traders
Technical analysis trends DAVITA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 81,5 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Kent J. Thiry Chairman & Chief Executive Officer
Joel Ackerman Chief Financial Officer
George R. Aronoff Chief Medical Officer
Peter Thacher Grauer Lead Independent Director
John M. Nehra Independent Director
Sector and Competitors